BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 12466135)

  • 1. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
    Xu J; Jian B; Chu R; Lu Z; Li Q; Dunlop J; Rosenzweig-Lipson S; McGonigle P; Levy RJ; Liang B
    Am J Pathol; 2002 Dec; 161(6):2209-18. PubMed ID: 12466135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.
    Jian B; Xu J; Connolly J; Savani RC; Narula N; Liang B; Levy RJ
    Am J Pathol; 2002 Dec; 161(6):2111-21. PubMed ID: 12466127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.
    Kurrasch-Orbaugh DM; Watts VJ; Barker EL; Nichols DE
    J Pharmacol Exp Ther; 2003 Jan; 304(1):229-37. PubMed ID: 12490596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart disease.
    Kekewska A; Hübner H; Gmeiner P; Pertz HH
    J Pharmacol Exp Ther; 2011 Jul; 338(1):381-91. PubMed ID: 21518772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors.
    Watts SW; Yang P; Banes AK; Baez M
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):539-51. PubMed ID: 11588524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.
    Banes A; Florian JA; Watts SW
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1179-87. PubMed ID: 10565840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT(2A) receptors stimulate mitogen-activated protein kinase via H(2)O(2) generation in rat renal mesangial cells.
    Greene EL; Houghton O; Collinsworth G; Garnovskaya MN; Nagai T; Sajjad T; Bheemanathini V; Grewal JS; Paul RV; Raymond JR
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F650-8. PubMed ID: 10751227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
    López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
    Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated cyclic stretch and serotonin result in altered aortic valve remodeling via a mechanosensitive 5-HT(2A) receptor-dependent pathway.
    Balachandran K; Hussain S; Yap CH; Padala M; Chester AH; Yoganathan AP
    Cardiovasc Pathol; 2012; 21(3):206-13. PubMed ID: 21865058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
    Berg KA; Maayani S; Goldfarb J; Scaramellini C; Leff P; Clarke WP
    Mol Pharmacol; 1998 Jul; 54(1):94-104. PubMed ID: 9658194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism.
    Parrish JC; Nichols DE
    J Neurochem; 2006 Nov; 99(4):1164-75. PubMed ID: 17010161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
    Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
    Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats.
    Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE
    Behav Pharmacol; 2002 Jul; 13(4):313-8. PubMed ID: 12218512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal Transduction Mechanism for Serotonin 5-HT2B Receptor-Mediated DNA Synthesis and Proliferation in Primary Cultures of Adult Rat Hepatocytes.
    Naito K; Tanaka C; Mitsuhashi M; Moteki H; Kimura M; Natsume H; Ogihara M
    Biol Pharm Bull; 2016; 39(1):121-9. PubMed ID: 26567725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling.
    Barthet G; Framery B; Gaven F; Pellissier L; Reiter E; Claeysen S; Bockaert J; Dumuis A
    Mol Biol Cell; 2007 Jun; 18(6):1979-91. PubMed ID: 17377064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiserotonergic properties of terguride in blood vessels, platelets, and valvular interstitial cells.
    Kekewska A; Görnemann T; Jantschak F; Glusa E; Pertz HH
    J Pharmacol Exp Ther; 2012 Feb; 340(2):369-76. PubMed ID: 22049464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells.
    Tsuchioka M; Takebayashi M; Hisaoka K; Maeda N; Nakata Y
    J Neurochem; 2008 Jul; 106(1):244-57. PubMed ID: 18363829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction.
    Florian JA; Watts SW
    J Pharmacol Exp Ther; 1998 Jan; 284(1):346-55. PubMed ID: 9435197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function.
    Jennings KA; Sheward WJ; Harmar AJ; Sharp T
    Neuropharmacology; 2008 Apr; 54(5):776-83. PubMed ID: 18241894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.